secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0001567264-24-000021
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics removes James Ahlers as officer; stays as consultant
---------------------------------------------------------------------------

- James Ahlers removed as officer effective May 21, 2024 per board resolution.
- No longer designated as executive officer under Rule 16a-1(f) or Rule 3b-7.
- Will continue in senior corporate finance consulting role via existing agreement with Danforth Advisors LLC.
- Removal not due to any disagreement with company operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726424000021/0001567264-24-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726424000021/intensity-20240521.htm
  HTML page:      https://secwatch.observer/filing/0001567264-24-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer